The aim of this review is to address the role of AGE, RAGE, and sRAGE as pathogenetic, diagnostic, and prognostic molecules in obesity and obesity-related CVD, as well as to describe available strategies for reducing AGE–RAGE system activation and the associated beneficial effects. The gene discussed is AGER; the disease is Obesity.